Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (Q167209): Difference between revisions

From geokb
(‎Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1)
(‎Changed label, description and/or aliases in en, and other parts: removed aliases from OpenAlex keywords)
 
(One intermediate revision by the same user not shown)
aliases / en / 0aliases / en / 0
Chronic Lymphocytic Leukemia
aliases / en / 1aliases / en / 1
Genomic Aberrations
aliases / en / 2aliases / en / 2
BTK Inhibitors
aliases / en / 3aliases / en / 3
Rituximab
aliases / en / 4aliases / en / 4
Ibrutinib
aliases / en / 5aliases / en / 5
Prognostic Factors
aliases / en / 6aliases / en / 6
TP53 Mutation
aliases / en / 7aliases / en / 7
Waldenström Macroglobulinemia
aliases / en / 8aliases / en / 8
Immunoglobulin Mutation
aliases / en / 9aliases / en / 9
Therapeutic Targets
Property / same as
 
Property / same as: https://openalex.org/T11157 / rank
Normal rank
 
Property / OpenAlex ID
 
Property / OpenAlex ID: T11157 / rank
 
Normal rank

Latest revision as of 21:11, 12 September 2024

Study of CLL's genetic mutations and treatment options.
Language Label Description Also known as
English
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
Study of CLL's genetic mutations and treatment options.

    Statements

    0 references
    0 references